E-LIB Suche - Ergebnisse für: Marschollek, Paweł

1

Immunophenotypic CAR-T Cells Heterogeneity of Pre- and Post..:

Oszer, Aleksandra ; Pawlik, Bartłomiej ; Crawford, Jeremy Chase...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S205 , 2024

Link: https://doi.org/10.1016/..

2

The Impact of High CMV Viral Load and Refractory CMV Infect..:

Szmit, Zofia ; Frączkiewicz, Jowita ; Salamonowicz-Bodzioch, Małgorzata...
Journal of Clinical Medicine. 11 (2022) 17 - p. 5187 , 2022

Link: https://doi.org/10.3390/..

3

Blinatumomab Prior to CAR-T Cell Therapy—A Treatment Option..:

Marschollek, Paweł ; Liszka, Karolina ; Mielcarek-Siedziuk, Monika...
Biomedicines. 10 (2022) 11 - p. 2915 , 2022

Link: https://doi.org/10.3390/..

4

Successful Salvage Haploidentical Bone Marrow Transplantati..:

Liszka, Karolina ; Marschollek, Pawel ; Gul, Katarzyna...
Transplantation Proceedings. 53 (2021) 8 - p. 2498-2501 , 2021

Link: https://doi.org/10.1016/..

5

Social participation of patients with multiple sclerosis:

Pokryszko-Dragan, Anna ; Marschollek, Karol ; Chojko, Aleksandra...
Advances in Clinical and Experimental Medicine. 29 (2020) 4 - p. 469-473 , 2020

Link: https://doi.org/10.17219..

6

New methods of differentiation between primary and secondar..:

Rasała, Julia ; Marschollek, Paweł ; Marschollek, Karol...
Advances in Clinical and Experimental Medicine. 29 (2020) 11 - p. 1299-1304 , 2020

Link: https://doi.org/10.17219..

7

Oncologists and Breaking Bad News—From the Informed Patient..:

Marschollek, Paweł ; Bąkowska, Katarzyna ; Bąkowski, Wojciech..
Journal of Cancer Education. 34 (2018) 2 - p. 375-380 , 2018

Link: https://doi.org/10.1007/..

8

Comparison of the Incidence of Complications and Secondary ..:

Janczak, Dariusz ; Malinowski, Maciej ; Bąkowski, Wojciech...
Annals of Thoracic and Cardiovascular Surgery. 23 (2017) 3 - p. 135-140 , 2017

Link: https://doi.org/10.5761/..

9

Developmental prosopagnosia in Poland: an analysis of onlin..:

KAROL MARSCHOLLEK ; MARTA NOWAKOWSKA-KOTAS ; PAWEŁ MARSCHOLLEK...
E-methodology. 6 (2020) 6 - p. 57-64 , 2020

Link: https://doi.org/10.15503..

10

The Impact of High CMV Viral Load and Refractory CMV Infect..:

Szmit, Zofia ; Frączkiewicz, Jowita ; Salamonowicz-Bodzioch, Małgorzata...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456677/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Blinatumomab Prior to CAR-T Cell Therapy—A Treatment Option..:

Marschollek, Paweł ; Liszka, Karolina ; Mielcarek-Siedziuk, Monika...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687755/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Comparison of the Incidence of Complications and Secondary ..:

Janczak, Dariusz ; Malinowski, Maciej ; Bąkowski, Wojciech...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483860/. , 2017

Link: http://www.ncbi.nlm.nih...

13

Blinatumomab Prior to CAR-T Cell Therapy—A Treatment Option..:

Paweł Marschollek ; Karolina Liszka ; Monika Mielcarek-Siedziuk...
https://www.mdpi.com/2227-9059/10/11/2915. , 2022

Link: https://doi.org/10.3390/..

14

The Impact of High CMV Viral Load and Refractory CMV Infect..:

Zofia Szmit ; Jowita Frączkiewicz ; Małgorzata Salamonowicz-Bodzioch...
https://www.mdpi.com/2077-0383/11/17/5187. , 2022

Link: https://doi.org/10.3390/..

15

The Impact of High CMV Viral Load and Refractory CMV Infect..:

Zofia Szmit ; Jowita Frączkiewicz ; Małgorzata Salamonowicz-Bodzioch...
Hematology. , 2022

Link: https://doi.org/10.3390/..